IVD Medical (HKG:1931) has partnered with HashKey under a global strategic cooperation framework to fast-track its "global enhanced Ethereum vault" strategy, according to an Aug. 8 Hong Kong bourse filing.
Shares of the medical equipment manufacturer were up nearly 14% in Monday's recent trade.
The deal will tap HashKey's licensed platforms for ETH trading, cost optimisation, and global liquidity, while enhancing capital allocation for medical R&D and expanding the group's Web3 footprint.
Separately, IVD Medical completed its first ETH reserve purchase, acquiring 5,190 ETH at an average HK$28,798.21 each for HK$149.47 million via HashKey Exchange.
It plans to invest up to HK$880 million in ETH and grow holdings through regular investments, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。